Management Archives - Page 26 of 341

2 minute read

Butler Hall Capital Has Issued An Open Letter To VNDA’s Board Of Directors Urging The Company To Run A Full Sales Process To Maximize Shareholder Value

April 19, 12:12 PM

https://ml.globenewswire.com/Resource/Download/9ee5bd01-bdbc-43f7-af2d-e4c34004b336Dear Members of the Board: A fund managed by Butler Hall Capital LLC, ("Butler Hall", "we" or "our") with current ownership of

VNDA

2 minute read

Genius Group Appoints Michael Moe As Non Executive Chairman Of Its Board

By Benzinga Newsdesk

April 19, 12:02 PM

Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered education group, today announced the appointment of Mr. Michael Moe as Non Executive Chairman of its Board. He has been appointed in

GNS

1 minute read

Tesla Shareholder Vote: Musk Receives Backing From 10th Biggest Investor For Pay Plan — Will Others Follow?

By Anan Ashraf

April 19, 8:48 AM

With 22.4 million shares held as of Dec. 31, their vote carries substantial weight.

TSLA

2 minute read

Management Expert Warns Elon Musk Faces ‘CEO Overload’ After Tesla Layoffs Reportedly Leave Him Overseeing 35 Key Personnel

By Shanthi Rexaline

April 19, 8:12 AM

Global sales teams, previously under the leadership of Tom Zhu since his promotion last April, have now been placed back under Musk's oversight.

TSLA

2 minute read

Google’s DeepMind to Lead Unified AI Charge as Company Seeks to Outpace Microsoft

By Anusuya Lahiri

April 19, 7:07 AM

Sundar Pichai, Google CEO, announces leadership and operational restructuring to accelerate AI development in response to criticism.

AAPL

3 minute read

Inhibikase Therapeutics Issues Letter To Shareholders And Provides Update On Development Programs; Says 201 Trial Is ~75% Enrolled

By Benzinga Newsdesk

April 18, 4:37 PM

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"),

IKT

1 minute read

BP’s New Approach: Streamlines Structure For Efficiency And Clarity

By Lekha Gupta

April 18, 11:29 AM

BP (NYSE: BP) simplifying organizational structure, integrating regions & functions, while retaining financial reporting structure.

3 minute read

Telesis Bio Inc. Announces Strategic Focus On Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform And BioXp mRNA Solutions; Todd R. Nelson To Step Down As CEO, Eric Esser, President And COO Of Telesis Bio, Will Assume The Role Of The Co’s CEP,…

By Benzinga Newsdesk

April 18, 9:17 AM

Telesis Bio Inc. (NASDAQ:TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform.

TBIO

2 minute read

Renovaro Announces The Appointment Of Professor Dr. Geert Kazemier As The Chairman Of Its Scientific Advisory Board

By Benzinga Newsdesk

April 18, 8:55 AM

Renovaro Inc. (NASDAQ:RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, announces the distinguished Professor Geert Kazemier, MD, PhD, as the new Chairman of its Scientific

RENB

1 minute read

Dario Signs Two Employers For Cardiometabolic Suite With Integrated GLP-1 Solution, Beginning In Q2 Of 2024

By Benzinga Newsdesk

April 18, 8:34 AM

Dario selected to provide integrated and proven solutions to improve employee cardiometabolic healthNEW YORK, April 18, 2024 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leader in the

DRIO